Eric Pauwels, CHIEF BUSINESS OFFICER at PTC THERAPEUTICS, INC. (PTCT), sold 5,699 shares at $29.01 ($165K) on 2024-01-09, disclosed to the SEC on 2024-01-10.
Scheduled sale ($165k) by CHIEF BUSINESS OFFICER under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $28.64 | 1,569 | $45K | 27.3% |
| 2 | $29.01 | 2,065 | $60K | 36.4% |
| 3 | $29.01 | 2,065 | $60K | 36.4% |
| Total | $28.91 avg | 5,699 | $165K | 100% |
| Filing → |
| PTCT | SELL | 2026-01-12 | $566K | — | Filing → |
| PTCT | SELL | 2026-01-08 | $242K | — | Filing → |
| PTCT | SELL | 2025-12-23 | $3.0M | — | Filing → |